Targeted integration of adeno‐associated virus (AAV) into human chromosome 19.

R. Jude Samulski(University of North Carolina at Chapel Hill), Lynne A. Hunter(University of Pittsburgh), J. David Brook(University of Nottingham), Xiangwei Xiao(University of Pittsburgh), Nava Epstein(University of Wisconsin–Madison), Xiaodong Zhu(University of Pittsburgh), David E. Housman(Massachusetts Institute of Technology)
The EMBO Journal
December 1, 1991
10.1002/j.1460-2075.1991.tb04964.x
Cited by 774

Related Papers

Long-term results of dual-chamber (DDD) pacing in obstructive hypertrophic cardiomyopathy. Evidence for progressive symptomatic and hemodynamic improvement and reduction of left ventricular hypertrophy.
|Circulation|1994|383
Contribution of Global Rare Copy-Number Variants to the Risk of Sporadic Congenital Heart Disease
|The American Journal of Human Genetics|2012|338
M2 macrophages promote beta-cell proliferation by up-regulation of SMAD7
|Proceedings of the National Academy of Sciences|2014|318
Pharmacological promotion of inclusion formation: A therapeutic approach for Huntington’s and Parkinson’s diseases
|Proceedings of the National Academy of Sciences|2006|258
Skeletal muscle expression and abnormal function of beta-myosin in hypertrophic cardiomyopathy.
|Journal of Clinical Investigation|1993|242